SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-006355
Filing Date
2018-05-15
Accepted
2018-05-15 16:52:40
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0318_americanbrivision.htm 10-Q 393313
2 CERTIFICATION f10q0318ex31-1_americanbriv.htm EX-31.1 14283
3 CERTIFICATION f10q0318ex31-2_americanbriv.htm EX-31.2 14898
4 CERTIFICATION f10q0318ex32-1_americanbriv.htm EX-32.1 5312
5 CERTIFICATION f10q0318ex32-2_americanbriv.htm EX-32.2 5441
  Complete submission text file 0001213900-18-006355.txt   2434580

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abvc-20180331.xml EX-101.INS 363066
7 XBRL SCHEMA FILE abvc-20180331.xsd EX-101.SCH 34325
8 XBRL CALCULATION FILE abvc-20180331_cal.xml EX-101.CAL 36614
9 XBRL DEFINITION FILE abvc-20180331_def.xml EX-101.DEF 81817
10 XBRL LABEL FILE abvc-20180331_lab.xml EX-101.LAB 190319
11 XBRL PRESENTATION FILE abvc-20180331_pre.xml EX-101.PRE 160302
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 18837416
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1